Thyroglobulin antibodies Blood Test: Ranges | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Thyroglobulin antibodies blood test

Thyroglobulin antibodies (TgAb, anti-Tg). Also called: TgAb, Anti-Tg, Anti-thyroglobulin antibodies, Antithyroglobulin antibody, Thyroglobulin antibody

Biomarker guideLast updated: November 3, 2026

Thyroglobulin antibodies attack thyroglobulin, the protein the thyroid stores hormone in. They mark thyroid autoimmunity and, after thyroid cancer, can mask the thyroglobulin tumor marker. Quest reads above 2 IU/mL as high.

LOINC 8098-6Hormones

At a glance

What it measuresAntibodies against thyroglobulin, the protein in which the thyroid makes and stores its hormone.
SampleSerum, 1 mL. Stop high-dose biotin at least 72 hours before.
Adult cut-offsQuest 2 IU/mL or lower; Labcorp reports any result above the assay's detection limit as elevated (reference limit below 4 IU/mL).
PeptidesNo peptide has been shown to change them: they did not change significantly on Exenatide, and case reports link Leuprolide and Triptorelin to new thyroiditis.
Lab codeLOINC 8098-6 (Labcorp 006685, Quest 267; both antibodies: Labcorp 006684, Quest 7260)

What are Thyroglobulin antibodies?

Thyroglobulin is the large protein in which the thyroid makes and stores thyroid hormone. Antibodies against it are a marker of autoimmune thyroiditis (Hashimoto's) and are also found in Graves disease. They have a second use in thyroid cancer care: when present, they make thyroglobulin tumor-marker results falsely low, so guidelines require thyroglobulin antibodies to be measured with every thyroglobulin test.

Sources: [1] [2] [3]

How it is made and regulated

Where it is made

The immune system makes antibodies against the body's own thyroglobulin. They were among the first autoantibodies described, in Hashimoto's disease.

Sources: [4] [5]

What controls it

Their presence is not always a sign of disease, especially at very low levels: about 10% of the general population has them, and 3% of people with no risk factors have them without TPO antibodies.

Sources: [1]

How it travels in the blood

When present, they bind thyroglobulin in the blood sample and make thyroglobulin immunoassay results falsely low or undetectable, which can hide thyroid cancer.

Sources: [1] [3]

How long it lasts

After treatment for differentiated thyroid cancer, the trend matters: a rising or new thyroglobulin antibody level may indicate recurrence, and a progressive decline suggests successful treatment.

Sources: [1]

What it does

As a marker of autoimmunity they add little to TPO antibodies, which are more sensitive; European guidance tests them when TSH is above 2.5 and TPO antibodies are not raised. Both labs offer the two antibodies together.

Sources: [6] [7] [8] [9]

Reference ranges

The labs read this test differently. Quest prints a cut-off; Labcorp reports any detectable result as elevated, based on a reference limit below 4 IU/mL. Neither lab prints a range for children or pregnancy.

Quest Diagnostics (test 267)

Method: Immunoassay. Quest Diagnostics test page (retrieved November 3, 2026).

GroupRange (IU/mL)
Reference range2 or lower

From Quest's test directory; the same cut-off is used on Quest's combined antibody test (7260).

Labcorp (test 006685)

Method: Immunochemiluminometric assay (ICMA), Beckman Coulter. Labcorp test page (retrieved November 3, 2026).

GroupRange (IU/mL)
Reference upper limit (validation study)below 4

Labcorp's page prints no reference-range field. Its validation found a 95% upper reference limit below 4 IU/mL, with 96% of 519 samples below 4, and it reports results above the limit of detection as elevated.

Cut-offs are specific to each assay, so results cannot be compared between labs.

Sources: [2] [1]

Is there an "optimal" range?

There is no "optimal" thyroglobulin antibody level. The questions are where to set the cut-off and what a low positive means.

A fixed cut-off

2 IU/mL or lower

Quest 267

Quest flags results above its cut-off.

Sources: [2]

Any detectable antibody

Above the limit of detection

Labcorp 006685

Labcorp reports detectable results as elevated, mainly because even low levels can interfere with thyroglobulin cancer testing.

Sources: [1]

Low levels are not always disease

About 10% of people are positive

Labcorp, citing NHANES III

Thyroglobulin antibodies are not always pathogenic or diagnostic, especially at very low levels.

Sources: [1]

A second-line autoimmunity test

Use when TPO antibodies are negative

European Thyroid Association (2013, 2021)

TPO antibodies are the more sensitive test; thyroglobulin antibodies are added when TSH is above 2.5 and TPO antibodies are not raised.

Sources: [6] [7]

What raises it

FactorHowHow much
Hashimoto's (chronic autoimmune thyroiditis)ConditionLabcorp uses the test to detect and confirm autoimmune and Hashimoto thyroiditis.No published magnitude [1]
Graves disease and goiterConditionQuest lists Graves disease and some types of goiter among the conditions it helps diagnose.No published magnitude [2]
Thyroid cancer recurrenceConditionAfter treatment for differentiated thyroid cancer, a rising or new antibody level may indicate recurrence.No published magnitude [1]
GnRH agonists (case reports)PeptideCase reports describe thyroiditis with positive antibodies after Leuprolide or Triptorelin.No published magnitude [10] [11]
Asfotase alfa (false result)MedicationQuest notes that Strensiq (asfotase alfa) may falsely raise the result.No published magnitude [2]

What lowers it

FactorHowHow much
Successful thyroid cancer treatmentConditionA progressive decline after treatment for differentiated thyroid cancer suggests successful treatment.No published magnitude [1]
Recovery from painless thyroiditisConditionIn a case of thyroiditis after Leuprolide, the antibodies gradually decreased as the thyroid recovered.No published magnitude [10]

Peptides that affect Thyroglobulin antibodies

How each peptide in our library has been shown to change thyroglobulin antibodies. The evidence is thin: one study measured them before and after a peptide (Exenatide, no significant change), and the GnRH-agonist rows are case reports. A single case of thyroiditis on Tirzepatide was antibody-negative and is not listed as a row. Somatostatin-receptor peptides appear in thyroid cancer research only as imaging and treatment tools, with thyroglobulin antibodies as a cancer marker; they do not change the antibodies. No study has measured thyroglobulin antibodies after dosing Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, Retatrutide, Thymosin Alpha-1, Thymulin, TB-500, LL-37, KPV, Selank, Semax, BPC-157, the growth hormone peptides or Leptin in people; PubMed searches for each find no human titer data. The rest of our library has no human thyroglobulin antibody data either.

PeptideEffect on Thyroglobulin antibodiesSize of effectEvidence
ExenatideNo clear effect39 obese adults with type 2 diabetes, exenatide 5 then 10 μg twice daily for 6 months (before-after, no control group): anti-Tg median 0.6 to 2 IU/mL (p = 0.847), while TSH and thyroid volume fellThyroglobulin antibodies did not change significantly over 6 months on exenatide. [12]Human trials
LeuprolideUnclearCase report, no titer figures: a 45-year-old woman given monthly leuprolide acetate injections for uterine leiomyoma developed silent (painless) thyroiditis two weeks after the fifth injection, with positive anti-Tg and anti-TPO antibodies; the antibodies gradually decreased as thyroid function recovered without treatment over five monthsOne case of painless thyroiditis with positive thyroglobulin antibodies after months of leuprolide; antibodies fell as it resolved. [10]Human trials
TriptorelinUnclearCase series, no titer figures: three women had transient hyperthyroidism 2 weeks after a triptorelin injection; antithyroglobulin (TgAb) and/or antithyroid microsome antibodies were positive in two of them, TRAb was negative in all three, and thyroid function was normal again by four weeksThree cases of brief thyroiditis-type hyperthyroidism after triptorelin, with thyroglobulin antibodies positive in some. [11]Human trials

What high or low results can mean

A high result

Above 2 IU/mL at Quest, or any detectable result at Labcorp, is positive. With TPO antibodies or a raised TSH it supports autoimmune thyroiditis; on its own and at low levels it is less meaningful. After thyroid cancer treatment it means thyroglobulin results may be falsely low.

  • Hashimoto's (chronic autoimmune thyroiditis)
  • Graves disease
  • Differentiated thyroid cancer
  • Low-level antibodies without disease

Next step: Read it with TPO antibodies and TSH. In thyroid cancer follow-up, discuss the trend and what it means for your thyroglobulin results.

Sources: [2] [1] [3]

A low result

Below the cut-off is negative. In thyroid cancer follow-up, a negative result means the thyroglobulin tumor marker can be read at face value.

  • No thyroglobulin antibodies

Next step: If thyroid autoimmunity is still suspected, TPO antibodies are the more sensitive test.

Sources: [2] [1] [6]

How the test works

SampleSerum, 1 mL at both labs (red-top or gel-barrier tube at Labcorp).
FastingLabcorp lists no fasting requirement.
TimingOrdered with TPO antibodies when thyroid autoimmunity is suspected, and with every thyroglobulin test in thyroid cancer follow-up. Stop high-dose biotin at least 72 hours before; asfotase alfa (Strensiq) can falsely raise the result at Quest.
Lab differencesImmunoassays reported in IU/mL: an immunochemiluminometric assay (Beckman Coulter) at Labcorp and an immunoassay at Quest. Cut-offs are assay-specific.
RetestingIn autoimmune thyroiditis, repeat testing does not help. In thyroid cancer follow-up, it is measured with every thyroglobulin test, in the same lab, to follow the trend.
Labcorp order code006685: Thyroglobulin Antibody
Labcorp order code006684: Thyroid Antibodies (TPO and thyroglobulin)
Quest Diagnostics order code267: Thyroglobulin Antibodies
Quest Diagnostics order code7260: Thyroid Peroxidase and Thyroglobulin Antibodies
LOINC codes
  • 8098-6: Thyroglobulin Ab [Units/volume] in Serum or Plasma
  • 56536-6: Thyroglobulin Ab [Units/volume] in Serum or Plasma by Immunoassay (method-specific code; neither lab reports it)
  • 87556-7: Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma (the TPO and thyroglobulin antibody pair)
LOINC 8098-6 on loinc.org

Sources: [1] [2] [6] [3]

History

Thyroglobulin antibodies were the first thyroid autoantibodies found, and today they are as important in thyroid cancer care as in autoimmunity.

  1. 1956Roitt and colleagues describe auto-antibodies in Hashimoto's disease. [4]
  2. 1958Roitt and colleagues report on the nature of the thyroid auto-antibodies in Hashimoto's thyroiditis. [5]
  3. 2023An expert consensus sets out how thyroglobulin and thyroglobulin antibodies should be measured together in thyroid cancer care. [3]

FAQ

What is a normal thyroglobulin antibody level?

Quest prints 2 IU/mL or lower. Labcorp reports any result above its assay's detection limit as elevated, based on a reference limit below 4 IU/mL.

Sources: [2] [1]

What does a high thyroglobulin antibody mean?

It shows the immune system is reacting against the thyroid, as in Hashimoto's or Graves disease. At low levels it is not always a sign of disease: about 10% of the general population has them.

Sources: [1] [2]

Do I have Hashimoto's if my thyroglobulin antibodies are positive?

Not necessarily. Hashimoto's is diagnosed from TSH, free T4 and TPO antibodies, which are the more sensitive test. Thyroglobulin antibodies alone, especially at low levels, are weaker evidence.

Sources: [6] [1]

What is the difference between thyroglobulin and TPO antibodies?

They target different thyroid proteins. TPO antibodies are more sensitive for thyroid autoimmunity; 3% of people with no risk factors have thyroglobulin antibodies without TPO antibodies.

Sources: [6] [1]

Why are thyroglobulin antibodies tested in thyroid cancer?

Thyroglobulin is the tumor marker after treatment for differentiated thyroid cancer, and these antibodies make its results falsely low or undetectable, which can hide disease. Guidelines require them to be measured with every thyroglobulin test.

Sources: [1] [3]

What does a rising thyroglobulin antibody mean after thyroid cancer?

A rising or new antibody level may indicate recurrence, while a progressive decline suggests successful treatment. Follow the trend in the same lab.

Sources: [1]

Why do Labcorp and Quest read the test differently?

They use different assays: Quest prints a cut-off of 2 IU/mL, while Labcorp reports any detectable result as elevated. Compare results from the same lab.

Sources: [2] [1]

What do thyroid antibodies mean for pregnancy and fertility?

European guidance suggests testing TSH and TPO antibodies in women of subfertile couples planning IVF, because raised TPO antibodies can identify women at risk of hypothyroidism during pregnancy and of postpartum thyroiditis. Levothyroxine before conception did not improve outcomes in euthyroid antibody-positive women: in the TABLET trial of 952 women, live births were 37.4% on levothyroxine and 37.9% on placebo. The American Thyroid Association updated its pregnancy guideline in 2026.

Sources: [7] [13] [14]

Should thyroglobulin antibodies be rechecked?

For autoimmune thyroiditis, usually not: repeated antibody measurements do not improve monitoring. After thyroid cancer, yes: they are measured with every thyroglobulin test.

Sources: [6] [1]

Do I need to stop biotin before the test?

Yes, if you take high-dose biotin: Labcorp asks you to stop at least 72 hours before.

Sources: [1]

Do any peptides affect thyroglobulin antibodies?

None has been shown to. They did not change significantly over 6 months on Exenatide (median 0.6 to 2 IU/mL, p = 0.847), and case reports link Leuprolide and Triptorelin to thyroiditis with positive antibodies. No study has measured them on Semaglutide, Tirzepatide or Thymosin Alpha-1.

Sources: [12] [10] [11]

References

  1. Labcorp. Test 006685: Thyroglobulin Antibody. Use, limitations, methodology, reference-limit studies, specimen requirements and LOINC map. labcorp.com/tests/006685/thyroglobulin-antibody
  2. Quest Diagnostics. Test code 267: Thyroglobulin Antibodies. Test directory: methodology, clinical significance, reference range and LOINC. testdirectory.questdiagnostics.com/test/test-detail/267/thyroglobulin-antibodies?cc=PHP
  3. Giovanella L, D'Aurizio F, Algeciras-Schimnich A, et al. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. Eur J Endocrinol. 2023;189(2):R11-R27. PMID 37625447
  4. ROITT IM, DONIACH D, CAMPBELL PN, et al. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet. 1956;271(6947):820-1. PMID 13368530
  5. ROITT IM, CAMPBELL PN, DONIACH D. The nature of the thyroid auto-antibodies present in patients with Hashimoto's thyroiditis (lymphadenoid goitre). Biochem J. 1958;69(2):248-56. PMID 13546173
  6. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. PMID 24783053
  7. Poppe K, Bisschop P, Fugazzola L, et al. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur Thyroid J. 2021;9(6):281-295. PMID 33718252
  8. Labcorp. Test 006684: Thyroid Antibodies (thyroid peroxidase and thyroglobulin antibodies). Components and LOINC map. labcorp.com/tests/006684/thyroid-antibodies
  9. Quest Diagnostics. Test code 7260: Thyroid Peroxidase and Thyroglobulin Antibodies. Test directory: components, reference ranges and LOINC. testdirectory.questdiagnostics.com/test/test-detail/7260/thyroid-peroxidase-and-thyroglobulin-antibodies?cc=PHP
  10. Kasayama S, Miyake S, Samejima Y. Transient thyrotoxicosis and hypothyroidism following administration of the GnRH agonist leuprolide acetate. Endocr J. 2000;47(6):783-5. PMID 11228054
  11. Miao J, Yan Q, Wang L, et al. Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review. Gynecol Endocrinol. 2018;34(9):734-735. PMID 29484896
  12. Köseoğlu D, Özdemir Başer Ö, Berker D, et al. EXENATIDE TREATMENT REDUCES THYROID GLAND VOLUME, BUT HAS NO EFFECT ON THE SIZE OF THYROID NODULES. Acta Endocrinol (Buchar). 2020;16(3):275-279. PMID 33363646
  13. Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. N Engl J Med. 2019;380(14):1316-1325. PMID 30907987
  14. Korevaar TIM, Leung AM, Alexander EK, et al. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. Thyroid. 2026;36(5):481-544. PMID 42219800

Educational information, not medical advice. Lab ranges and test codes were checked on November 3, 2026. Always use the range printed on your own report, and talk to a clinician about your results.